Correction to: Diabetes Ther https://doi.org/10.1007/s13300-020-00917-8

In the original article, the sentence “The primary outcome of 3-point MACE occurred in significantly fewer participants receiving semaglutide (HR 0.79, CI 0.57–1.11)” was published with an error and should be discounted from the review. The authors wish to update this sentence instead to state that “Semaglutide resulted in numerically, albeit not statistically significantly, fewer CV events (HR 0.79, CI 0.57–1.11)”.

The original article has been corrected.